How NZ differs from Australia and the EU
New Zealand's medical device regulatory system is intentionally lighter than those of its closest regulatory neighbours — Australia and the EU. Understanding the key differences avoids both under-compliance (assuming NZ is a free pass) and over-compliance (applying full EU MDR logic where it is not required).
Pre-market requirements
| Aspect | New Zealand | Australia (TGA) | European Union |
|---|---|---|---|
| Pre-market approval | Not required | Required (ARTG) | Required (CE marking) |
| Regulator review before supply | No | Yes (for most classes) | Via Notified Bodies |
| Formal conformity assessment routes | None | Multiple prescribed routes | Annex IX–XI routes |
| Third-party body involvement | None required | For higher-risk classes | Notified Body for most devices |
Practical implication: You can supply a device in NZ that has not received formal approval anywhere — as long as you can produce safety and performance evidence on request and you have a NZ Sponsor who has notified WAND.
Accepted overseas evidence
Medsafe has confirmed it accepts the following as evidence of conformity:
- CE certificate from an EU Notified Body
- TGA registration (ARTG listing) from Australia
- FDA clearance or approval from the USA
- Health Canada licence from Canada
No specific conformity assessment procedure is mandated for the NZ market — but the evidence must exist and must be held by the Sponsor or manufacturer.
Labelling
| Aspect | New Zealand | Australia | EU |
|---|---|---|---|
| Mandatory UDI | No | Yes (staged rollout) | Yes |
| Language requirement | English | English | Language of country of supply |
| Reference standard | GHTF/SG1/N43:2005 | TGA Orders | EU MDR Annex I |
| IFU required? | Expected but not prescribed | Yes | Yes |
IVDs — a significant difference
In New Zealand, IVDs are exempt from mandatory WAND notification under Schedule 1 of the Medicines (Database of Medical Devices) Regulations 2003. They can be notified voluntarily, and many sponsors do so. In contrast, Australia has a full IVD regulatory framework with mandatory ARTG listing, and the EU has the IVDR.
Post-market surveillance
| Aspect | New Zealand | Australia | EU |
|---|---|---|---|
| Mandatory PSUR | No | Yes (for some classes) | Yes |
| Periodic safety reporting | Not prescribed | Yes | Yes |
| PMCF required | Not prescribed | For some classes | Yes |
| PMS plan required | Not prescribed | Yes | Yes |
NZ's approach is lighter — sponsors must report adverse events and manage recalls, but there is no formal periodic reporting cycle comparable to EU PSURs.
Classification alignment
New Zealand's 22 classification rules are based on the GHTF (Global Harmonization Task Force) framework and closely aligned with both the EU Medical Devices Directive and Australian TGA classification rules. However:
- The EU has since moved to the MDR (2017/745), which reclassified some device types upward
- Australia has aligned its classification rules with the EU MDR
- New Zealand has not yet adopted the MDR-era changes, so some discrepancies exist between NZ classes and EU/AU classes for certain device types
Always check classification under NZ Schedule 2 independently — do not assume your EU or AU class automatically carries over.
TTMRA — the special Australia–NZ arrangement
The Trans-Tasman Mutual Recognition Arrangement means that goods lawfully supplied in Australia can generally be supplied in NZ without separate NZ-specific regulatory approval. However, this does not eliminate WAND notification obligations for devices. See TTMRA and Australia for a full analysis.
Summary for manufacturers
Already have TGA, CE, or FDA clearance? You are well-positioned for the NZ market. Your existing evidence satisfies Medsafe's conformity evidence expectations. You still need a NZ Sponsor and must notify WAND within 30 days of supply commencing. Labelling may need minor adjustment.
No overseas regulatory clearance? You can still supply in NZ, but you must hold your own technical documentation, risk management records, and performance evidence — and a NZ Sponsor must be willing to take legal responsibility for the device.